Some health care providers in China have stopped welcoming representatives of multinational drugmakers in their offices since Chinese police accused some drugmakers of bribery. Growth in the sector has slowed as some drugmakers have scaled back marketing activities and dropped sales quotas for the quarter.

Full Story:

Related Summaries